Good leadership will always support businesses with excellent customer service, technical agility, and niche capabilities.
FREMONT, CA: Bora Pharmaceuticals, full-service contract development, and manufacturing organization (CDMO) with expertise in immediate and modified-release tablets and capsules, along with serialized packaging, announce the appointment of four business development directors to its commercial teams in the US and Taiwan. This appointment is a result of Bora’s continued demand for its CDMO services in North America, Asia, and Europe and to help the company’s planned acquisition of GSK’s facility in Mississauga, Canada.
The appointment includes Mark Dawson as Senior Director of Business Development to bring his wealth of CDMO sales expertise over the last decade, David Scheib as a Business Development Director with 20 years of experience in pharmaceutical sales, Kalyan Potluri as a Business Development Director who will be a charge of the Northeast US and Eastern Canada regions, and Wayne Hsiao as Asia Business Development Director with over 17 years sector experience in API business development and technical, regulatory services.
Bora Pharmaceuticals is excited about the addition of an experienced business development team. The next six months for Bora will be an exceptional turning point as the company completes the next phase of its expansion into North America with the acquisition of GSK’s world-class facility in Mississagua. With the Mississauga manufacturing facility, Bora can leverage Canadian talent, capability, capacity, and location to become a truly global contract development and manufacturing organization. The expansion with such an experienced business development team will also further the growth to support Bora’s global clientele. The company is really excited to see the impact the team can create in supporting the needs of pharmaceutical clients.
Bora is a leading full-service contract development and manufacturing organization (CDMO) that specializes in immediate release and complex modified release drug product manufacturing and serialized packaging for solid oral dosage forms.